整合单细胞与血浆蛋白组学建模预测手术部位并发症:一项前瞻性队列研究
整合POD1多组学数据的模型区分手术部位并发症(SSC)的AUC为0.86,术前数据模型AUC为0.82。结果表明围术期免疫数据整合有助于预测SSC。
要点
- 术后第1天多组学模型区分SSC患者(n=11)与无SSC患者(n=30)的AUC=0.86。
- 术前免疫数据模型也可准确预测SSC,AUC=0.82。
- 模型特征涉及髓系细胞中IL-6和MyD88信号及M-MDSC和Treg中JAK/STAT信号。
核心结论
- 术后和术前免疫应答的多组学分析揭示了SSC发生前的系统性免疫特征。
- 整合免疫数据至围术期风险评估范式可能是指导个体化临床治疗的可行策略。
研究设计与样本
- 术前和术后第1天采血,联合单细胞质谱流式和血浆蛋白组学分析。
- 主要结局为术后30天内SSC,包括手术部位感染、吻合口漏或伤口裂开。
主要发现
- 整合POD1单细胞和血浆蛋白组学数据的多组学模型区分SSC患者(n=11)与无SSC患者(n=30)的AUC=0.86。
- 术前免疫数据模型预测SSC的AUC=0.82。
- 模型特征包括SSC发生前髓系细胞中IL-6和MyD88信号应答及M-MDSC和Treg中JAK/STAT信号应答。
临床怎么用
- 围术期风险评估中可考虑整合免疫学数据以指导个体化临床治疗。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to determine whether single-cell and plasma proteomic elements of the host's immune response to surgery accurately identify patients who develop a surgical site complication (SSC) after major abdominal surgery. SUMMARY BACKGROUND DATA: SSCs may occur in up to 25% of patients undergoing bowel resection, resulting in significant morbidity and economic burden. However, the accurate prediction of SSCs remains clinically challenging. Leveraging high-content proteomic technologies to comprehensively profile patients' immune response to surgery is a promising approach to identify predictive biological factors of SSCs. METHODS: Forty-one patients undergoing non-cancer bowel resection were prospectively enrolled. Blood samples collected before surgery and on postoperative day one (POD1) were analyzed using a combination of single-cell mass cytometry and plasma proteomics. The primary outcome was the occurrence of an SSC, including surgical site infection, anastomotic leak, or wound dehiscence within 30 days of surgery. RESULTS: A multiomic model integrating the single-cell and plasma proteomic data collected on POD1 accurately differentiated patients with (n = 11) and without (n = 30) an SSC [area under the curve (AUC) = 0.86]. Model features included coregulated proinflammatory (eg, IL-6- and MyD88- signaling responses in myeloid cells) and immunosuppressive (eg, JAK/STAT signaling responses in M-MDSCs and Tregs) events preceding an SSC. Importantly, analysis of the immunological data obtained before surgery also yielded a model accurately predicting SSCs (AUC = 0.82). CONCLUSIONS: The multiomic analysis of patients' immune response after surgery and immune state before surgery revealed systemic immune signatures preceding the development of SSCs. Our results suggest that integrating immunological data in perioperative risk assessment paradigms is a plausible strategy to guide individualized clinical care.
引用
- Rumer KK, Hedou J, Tsai A, et al. Integrated Single-cell and Plasma Proteomic Modeling to Predict Surgical Site Complications: A Prospective Cohort Study. Ann Surg. 2022. PMID: 34954754. doi:10.1097/SLA.0000000000005348
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。